Veradermics Inc (MANE)

Finanzdaten der Veradermics Inc-Aktie (MANE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31
Periodenlänge	3 Monate	3 Monate
	1.03%29.55	29.86
Research and Development	11.08%18.61	20.93
Operating Income/Loss	1.03%-29.55	-29.86
Nonoperating Income/Loss	130.08%6.05	2.63
Income/Loss From Continuing Operations Before Tax	13.70%-23.50	-27.23
Income Tax Expense/Benefit	-	-
	13.70%-23.50	-27.23
Attributable To Parent	13.70%-23.50	-27.23
Available To Common Stockholders, Basic	21.69%-23.50	-30.01
Basic Average Shares	78.10%40.44	22.70
Diluted Average Shares	78.10%40.44	22.70
Basic Earnings Per Share	56.06%-0.58	-1.32
Diluted Earnings Per Share	56.06%-0.58	-1.32